Benspar Cap
MRP: ₹45.00
Packaging
10 CAP
Composition
Levodopa 100mg + Benserazide 28.5mg
Company
Zydus Cadila
MRP: ₹45.00
Packaging
10 CAP
Composition
Levodopa 100mg + Benserazide 28.5mg
Company
Zydus Cadila
| Medicine | Company | Price | You Save | |
|---|---|---|---|---|
| No substitutes available. | ||||
GI disturbances e.g. nausea, vomiting, anorexia. GI bleeding in peptic ulcer patients. Orthostatic hypotension, cardiac arrhythmias. Psychiatric symptoms (especially the elderly), depression with or without suicidal tendency. Abnormal involuntary movements or dyskinesias, delirium, hallucinations. Slight elevation of liver enzymes, BUN and uric acid. Transient leucopenia and thrombocytopenia.
Increased postural hypotension and possible reduced absorption with TCAs. Reduced effects with phenothiazines, butyrophenones, thioxanthenes and other antipsychotic agents; reserpine, papaverine, phenytoin, isoniazid. Reversal of effects of levodopa monotherapy with pyridoxine. Exacerbation of abnormal involuntary movements and possibly delayed absorption with anticholinergics. Additive hypotensive effects with antihypertensive agents. Increased CNS toxicity with methyldopa. Exacerbation of parkinsonian symptoms with metoclopramide. Potentially Fatal: Increased risk of hypertensive crises with nonselective MAOIs. Increased risk of cardiac arrhythmias with cyclopropane or halogenated anaesthetics.
Angle-closure glaucoma; malignant melanoma.
Levodopa increases dopamine levels in the brain leading to the stimulation of dopamine receptors. Absorption: Rapidly absorbed from the GI tract (oral); absorption reduced and delayed by food. Peak plasma concentrations within 2 hr. Distribution: Protein-binding: 10-30%. Penetrates the blood-brain barrier; crosses the placenta; distributed into breast milk. Metabolism: Metabolised in the gut, liver and kidney; decarboxylated by L-aminodecarboxylase to dihydrophenylacetic acid (DOPAC) and homovanillic acid (HVA). Other routes: O-methylation, transamination, oxidation. Excretion: Via urine within 24 hr (80% as metabolites); via faeces (minimal amounts). 30-60 min (elimination half-life).
Heart disease, liver or renal disease, pulmonary disease, endocrine disorders, seizure disorders, dementia or psychosis; open-angle glaucoma, osteomalacia, history of peptic ulcer. Monitor hepatic, psychiatric, haematological, renal and CV functions periodically. May impair ability to drive or operate machinery. Elderly. Avoid abrupt withdrawal. Pregnancy and lactation.
Take orally with food and water, as directed by your physician.
Keep in a cool, dry place away from sunlight and moisture.
This content is for educational purposes only. Please consult your doctor before use.
| Brand Name | Form | Price |
|---|---|---|
| Akostol 100 mg Tablet 10s | TAB | ₹79.00 |
| Aldonil 50mg Tab | TAB | ₹58.00 |
| Alupent Syrup 100ml | SYRUP | ₹75.00 |
| Alupent-10mg Tab | TAB | ₹48.00 |
| Amlodac 5mg Tablet 15s | TAB | ₹0.00 |
| Arnx 50mg Tablet 10s | TAB | ₹199.00 |
| Atorva TG Tablet 10s | TAB | ₹0.00 |
| Atorva-E Tab 10s | TAB | ₹0.00 |
| Avanext 200 Tablet 4s | TAB | ₹733.00 |
| Azildac 40mg Tablet 10s | TAB | ₹72.50 |
| Benspar Cap | CAP | ₹45.00 |
| Betanase-5mg Tab | TAB | ₹4.00 |
| Bilypsa 4mg Tablet 45s | TAB | ₹1,397.00 |
| Bql-10mg Tab | TAB | ₹28.00 |
| Bql-2.5mg Tab | TAB | ₹15.00 |
Written by: SastiMedic Medical Team
Reviewed by: Registered Pharmacist